# Breast Cancer Liquid Biopsy Stratification

> **NCT03992521** · — · UNKNOWN · sponsor: **Medical University of Graz** · enrollment: 59 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **GENETIC:** Nucleosome positioning

## Key facts

- **NCT ID:** NCT03992521
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-01
- **Primary completion:** 2023-10
- **Final completion:** 2023-10
- **Target enrollment:** 59 (ESTIMATED)
- **Last updated:** 2022-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03992521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03992521, "Breast Cancer Liquid Biopsy Stratification". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03992521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*